Anthemis invests in Humans

Deal terms as reported in the coverage below.

Decision brief

What changed

A Lisbon-based startup focused on insuring AI agents raised a $3.2 million seed round led by Anthemis. According to the coverage, the new funding is intended to expand the company’s product and operations.

Why it matters

This is a concrete signal that an institutional investor sees enough demand or strategic relevance in AI-agent risk management to back a specialist insurer-oriented startup. For business leaders deploying or building AI agents, it suggests the surrounding risk-transfer and governance market is starting to develop, which could affect how companies structure liability, vendor requirements, and enterprise adoption decisions.

Affected roles

CEO CFO COO CTO CISO

Evidence

The event is supported by one report from Sifted, which states that the Lisbon startup raised a $3.2 million seed round led by Anthemis and will use the capital to expand product and operations. Because the coverage is based on a single outlet and no additional independent reports are provided here, corroboration is limited.

What remains uncertain

The coverage does not specify the startup’s current product maturity, customer traction, underwriting model, or whether it is providing insurance directly or enabling risk assessment for insurers. It also does not show whether Anthemis’s investment reflects broader market validation versus an early thematic bet, and the company name appears inconsistent in the provided materials.

Monitor next

Watch for the startup’s next concrete disclosures on product launch, insurer partnerships, or named enterprise customers using its AI-agent risk offering.

Analytical support, not advice — assumptions and open questions stated above.

Source coverage